Activator of G-protein Signaling (AGS) proteins provide alternate modes of signal input to heterotrimeric G- proteins and diversify G-protein signaling through unexpected mechanisms. Group II AGS proteins contain 1-4 G-protein regulatory (GPR) motifs that serve as a docking site for Gi?-GDP free of G??. Group II AGS proteins include AGS3 and AGS5/LGN, which play important regulatory roles in cell division, neuronal development, synaptic plasticity, the biology of addiction, energy homeostasis, and cardiovascular functions. A long-term objective of this research effort is to determine the functional role of the Group II AGS protein AGS4 in regulating G-protein signaling with a specific focus on the immune system where AGS4 is enriched in lymphocytes. As the first approach to this longer term objective, this proposal addresses key questions related to the interaction of AGS4 with G-proteins and the impact of this interaction on signal processing in the cell.
SPECIFIC AIM #1 Determine the factors and mechanisms that influence AGS4 interaction with Gi? subunits to test the hypothesis that the AGS4-Gi? interaction is a regulated event.
SPECIFIC AIM #2 Determine the factors that influence the subcellular distribution of AGS4 to test the hypothesis that positioning of AGS4 is regulated and influences its interaction with G-protein.
SPECIFIC AIM #3 Determine the effect of altered AGS4 levels on G-protein signaling in S1A and Jurkat T cells to test the hypothesis that AGS4 modulates GPCR - G-protein signal processing. Group II AGS proteins like AGS4 provide insight into novel modes of signal input and regulation of heterotrimeric G-protein signaling and provide a platform for discovering mechanisms underlying signal strength, specificity, and integration of G-protein mediated cellular responses. Furthermore, they provide unexpected targets for development of therapeutics for diseases which result from altered heterotrimeric G-protein signaling.
The work proposed in this application focuses on basic mechanisms for regulation of a major system that controls function of various tissues in the body including the immune system. The area of investigation has merit from the perspective of disease diagnostics and the development of new therapeutic strategies.
|Robichaux 3rd, William G; Oner, Sukru S; Lanier, Stephen M et al. (2015) Direct Coupling of a Seven-Transmembrane-Span Receptor to a GÎ±i G-Protein Regulatory Motif Complex. Mol Pharmacol 88:231-7|
|Blumer, Joe B; Lanier, Stephen M (2014) Activators of G protein signaling exhibit broad functionality and define a distinct core signaling triad. Mol Pharmacol 85:388-96|
|Bradley, Amber; Zheng, Hui; Ziebarth, Angela et al. (2014) EDD enhances cell survival and cisplatin resistance and is a therapeutic target for epithelial ovarian cancer. Carcinogenesis 35:1100-9|
|Branham-O'Connor, Melissa; Robichaux 3rd, William G; Zhang, Xian-Kui et al. (2014) Defective chemokine signal integration in leukocytes lacking activator of G protein signaling 3 (AGS3). J Biol Chem 289:10738-47|
|Oner, Sukru Sadik; Blumer, Joe B; Lanier, Stephen M (2013) Group II activators of G-protein signaling: monitoring the interaction of GÃ½Ã½ with the G-protein regulatory motif in the intact cell. Methods Enzymol 522:153-67|
|Vellano, Christopher P; Brown, Nicole E; Blumer, Joe B et al. (2013) Assembly and function of the regulator of G protein signaling 14 (RGS14)Â·H-Ras signaling complex in live cells are regulated by GÎ±i1 and GÎ±i-linked G protein-coupled receptors. J Biol Chem 288:3620-31|
|Oner, Sukru Sadik; Maher, Ellen M; Gabay, Meital et al. (2013) Regulation of the G-protein regulatory-GÎ±i signaling complex by nonreceptor guanine nucleotide exchange factors. J Biol Chem 288:3003-15|
|Blumer, J B; Oner, S S; Lanier, S M (2012) Group II activators of G-protein signalling and proteins containing a G-protein regulatory motif. Acta Physiol (Oxf) 204:202-18|
|Kwon, Michelle; Pavlov, Tengis S; Nozu, Kandai et al. (2012) G-protein signaling modulator 1 deficiency accelerates cystic disease in an orthologous mouse model of autosomal dominant polycystic kidney disease. Proc Natl Acad Sci U S A 109:21462-7|
|Chan, PuiYee; Gabay, Meital; Wright, Forrest A et al. (2011) Purification of heterotrimeric G protein alpha subunits by GST-Ric-8 association: primary characterization of purified G alpha(olf). J Biol Chem 286:2625-35|
Showing the most recent 10 out of 16 publications